PIPELINE
Discover our pipeline
MIT-114 is an oral-route herbal medication that offers a promising therapeutic pathway for tinnitus. By targeting the underlying neuroplastic mechanisms, MIT-114’s unique neuroprotective properties are designed to restore auditory function.
The clinical data suggest that MIT-114 can:
Improve Cochlear Nerve function: By protecting and potentially repairing the delicate nerve fibres within the cochlea, MIT-114 aims to re-establish the integrity of the auditory signal at its source.
Enhance neural conduction: The composition is designed to optimize the transmission of these signals along the auditory pathway to the brain.
By strengthening the connection between the ear and the brain, MIT-114 may enable the central auditory system to process environmental sound more effectively. This could, in turn, reduce the brain’s maladaptive hyperactivity, leading to a significant decrease in the perception of tinnitus.
MIT-802
Itching is the main symptom in many dermatological diseases. It can also be caused by insect bites, contact with stinging plants, etc.
Mitelos is working on an innovative, highly tolerable formula that will offer a different approach to current treatments, with immediate soothing action and restoration of skin balance for long-lasting comfort.
MIT-218
The insertion of a peripheral intravenous cannula (PIVC) for intravenous fluids and medications is the most common procedure in hospitalized patients worldwide. A frequent PIVC complication is phlebitis, that is, inflammation of the vein, which may be mechanical,
chemical or bacterial in origin. Its treatment is a global unmet medical need.
Mitelos is committed to meeting this need and is already developing a specific product that it aims to bring to market in the coming years.
Need more information?
Contact us
